Deuterohemin-AlaHisLys mitigates the symptoms of rats with non-insulin dependent diabetes mellitus by scavenging reactive oxygen species and activating the PI3-K/AKT signal transduction pathway-Reference-Cited by-同舟云学术

Deuterohemin-AlaHisLys mitigates the symptoms of rats with non-insulin dependent diabetes mellitus by scavenging reactive oxygen species and activating the PI3-K/AKT signal transduction pathway

Published:2014-09 Issue: Volume:220 Page:64-74
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Lei Liyan^ORCID,Zhang Guangji,Li Pengfei,Zhang Yuan,Guo Youming,Zhang Wenqi,Zhang Wenbo,Hu Bing,Wang Liping

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference40 articles.

1. On the cyanide inactivation of succinic dehydrogenase and the relation of succinic dehydrogenase to cytochrome b;Tsou;Biochem. J.,1951

2. Hemes and hemoproteins. 5: kinetics of the peroxidatic activity of microperoxidase-8: model for the peroxidase enzymes;Baldwin;J. Inorg. Biochem.,1987

3. Microperoxidases catalytically degrade reactive oxygen species and may be anti-cataract agents;Spector;Exp. Eye Res.,1997

4. Catalysis by haemin of some molybdenum (VI) oxidations;Brown;Nature,1968

5. The peroxidase activity of deuterohemin;Portsmouth;Eur. J. Biochem.,1971

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesoporous molecularly imprinted nanoparticles with peptide mimics for the detection of phenolic compounds;Analytica Chimica Acta;2023-04

2. DhHP-6 ameliorates hepatic oxidative stress and insulin resistance in type 2 diabetes mellitus through the PI3K/AKT and AMPK pathway;Biochemical Journal;2020-06-26

3. Effect of the hairpin structure of peptide inhibitors on the blockade of PD-1/PD-L1 axis;Biochemical and Biophysical Research Communications;2020-06

4. Activity adaptability of a DhHP-6 peroxidase-mimic in wide pH and temperature ranges and solvent media;Catalysis Science & Technology;2020

5. Oral DhHP-6 for the Treatment of Type 2 Diabetes Mellitus;International Journal of Molecular Sciences;2019-03-26